angiotensin ii has been researched along with zelandopam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epstein, M; Forster, H; Takenaka, T | 1 |
| Arai, Y; Asano, M; Honda, K; Inagaki, O; Kasai-Nakagawa, C; Takanashi, M; Takenaka, T; Takizawa, K; Tanaka, A; Uchida, W; Yatsu, T | 1 |
| Asano, M; Honda, K; Kasai-Nakagawa, C; Takenaka, T; Takizawa, K; Tanaka, A; Uchida, W; Yatsu, T | 1 |
3 other study(ies) available for angiotensin ii and zelandopam
| Article | Year |
|---|---|
Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
Topics: Angiotensin II; Animals; Dopamine Agents; Endothelins; Isoquinolines; Kidney; Microcirculation; Perfusion; Rats; Receptors, Dopamine D1; Tetrahydroisoquinolines; Vasoconstriction; Vasodilator Agents | 1993 |
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Topics: Anesthesia; Angiotensin II; Animals; Benzazepines; Dogs; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hemodynamics; Infusions, Intravenous; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; Platelet Activating Factor; Receptors, Dopamine D1; Renal Circulation; Tetrahydroisoquinolines; Vasodilator Agents | 1997 |
Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Dogs; Dopamine; Female; Heart Rate; Hemodynamics; Hypertension; Isoquinolines; Male; Norepinephrine; Receptors, Dopamine D1; Renal Circulation; Tetrahydroisoquinolines; Vascular Resistance | 1997 |